bioRxivImmunology
Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?
Z.-R. T. Li, V. I. Zarnitsyna, A. C. Lowen, D. Weissman, K. Koelle, J. Kohlmeier, R. Antia
Abstract
The high-degree conservation of CD8 T cell epitopes of influenza A virus (IAV) may allow T cell-inducing vaccines effective across different strains and subtypes. This conservation is not fully explained by functional constraint, since additional mutation(s) can compensate the replicative fitness loss of IAV escape-variant. Here, we propose three additional mechanisms that contribute to the conservation of CD8 T cell epitopes of IAV. First, influenza-specific CD8 T cells may protect predominantly against severe pathology rather than infection and may only have a modest effect on transmission. Second, polymorphism of human MHC-I gene restricts the advantage of an escape-variant to only a small fraction of human population, who carry the relevant MHC-I alleles. Finally, infection with CD8 T cell-escapevariants may result in compensatory increase in the responses to other epitopes of IAV. A combination of population genetics and epidemiological models is used to examine how the interplay between these mechanisms affects the rate of invasion of IAV escape-variants. We conclude that the invasion of an escape-variant will be very slow with a timescale of decades or longer, even if the escape-variant does not have a replicative fitness loss. Our results suggest T cell-inducing vaccines may not engender the rapid evolution of IAV and serve as a foundation for future modeling works on the long-term effectiveness and impacts of T cell-inducing influenza vaccines. (Word count: 221)\n\nImportanceUniversal influenza vaccines against the conserved epitopes of influenza A virus have been proposed to minimize the burden of seasonal outbreaks and prepare for the pandemics. However, it is not clear to which extent the T cell-inducing vaccines will select for viruses that escape the T cell responses. Our mathematical models suggest how the nature of CD8 T cell protection contributes to the conservation of the CD8 T cell epitopes of influenza A virus. Also, it points out the essential biological parameters and questions that need addressing by future experimental works. (Word count: 91)
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Quantifying memory CD8 T cell-mediated immune pressure on influenza A virus infection in vivo
Z.-R. T. Li, V. I. Zarnitsyna, … J. E. Kohlmeier·bioRxiv·Jan 27, 2020
- Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge
X. Zheng, J. D. Oduro, … L. Cicin-Sain·bioRxiv·Dec 12, 2018
- Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations in ovo
A. K. F. Davis, K. McCormick, … S. E. Hensley·bioRxiv·May 17, 2018
- Broad heterologous protection against Influenza A viruses by an adjuvant-free modular mucosal T-cell vaccine platform.
Rajesh Thangavel Yadav, Mansi Sharma, … S.K. Tripathi·bioRxiv·Jun 5, 2026
- A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface
H. C. Simmons, J. Finney, … K. R. McCarthy·bioRxiv·Dec 13, 2023
- A Herpes Simplex Virus Type-1-derived influenza vaccine induces balanced adaptive immune responses and protects mice from lethal influenza virus challenge.